Pereira, Barry P <br/><br/>
Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).  [electronic resource] 

 -  Journal of cellular physiology  Dec 2009 
 - 778-88 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-4652 
<br/><br/><label>Standard No.: </label>10.1002/jcp.21921  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Animals<br/>Antigens, CD--metabolism<br/>Asian People<br/>Calcification, Physiologic--physiology<br/>Cell Cycle--drug effects<br/>Cell Dedifferentiation<br/>Cell Differentiation<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Child<br/>Chromosome Aberrations<br/>Collagen Type I--metabolism<br/>Core Binding Factor Alpha 1 Subunit--genetics<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>Cyclins--genetics<br/>Female<br/>Gene Expression--genetics<br/>Humans<br/>Ki-67 Antigen--metabolism<br/>Mice<br/>Mice, SCID<br/>Nocodazole--pharmacology<br/>Osteoblasts--pathology<br/>Osteocalcin--metabolism<br/>Osteosarcoma--diagnosis<br/>Retinoblastoma Protein--genetics<br/>Tumor Suppressor Protein p53--genetics<br/>Xenograft Model Antitumor Assays